Breast cancer: Aromatase inhibitors take on tamoxifen
- 1 December 2002
- journal article
- Published by Springer Nature in Nature Medicine
- Vol. 8 (12), 1341-1344
- https://doi.org/10.1038/nm1202-1341
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trialThe Lancet, 2002
- Molecular changes associated with the acquisition of oestrogen hypersensitivity in MCF-7 breast cancer cells on long-term oestrogen deprivationThe Journal of Steroid Biochemistry and Molecular Biology, 2002
- Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trialThe Lancet, 2002
- Influence of Letrozole and Anastrozole on Total Body Aromatization and Plasma Estrogen Levels in Postmenopausal Breast Cancer Patients Evaluated in a Randomized, Cross-Over StudyJournal of Clinical Oncology, 2002
- Endocrine-responsive breast cancer and strategies for combating resistanceNature Reviews Cancer, 2002
- Role of Low Levels of Endogenous Estrogen in Regulation of Bone Resorption in Late Postmenopausal WomenJournal of Bone and Mineral Research, 2002
- Letrozole Is More Effective Neoadjuvant Endocrine Therapy Than Tamoxifen for ErbB-1– and/or ErbB-2–Positive, Estrogen Receptor–Positive Primary Breast Cancer: Evidence From a Phase III Randomized TrialJournal of Clinical Oncology, 2001
- Modulation of epidermal growth factor receptor in endocrine-resistant, oestrogen receptor-positive breast cancer.Endocrine-Related Cancer, 2001
- Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 StudyJNCI Journal of the National Cancer Institute, 1998
- Recent advances in endocrine therapy of breast cancerBMJ, 1997